COVID-19 Vaccine Boosters | Influenza | October 6, 2021
Date of Presentation: October 6, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid clinical updates #covid updates
In this presentation, Dr. Jorge Mera, ECHO Medical Director and Director of Infectious Diseases for Cherokee Nation Health Services, and Whitney Essex, ECHO faculty member and Family Nurse Practitioner at Cherokee Nation Health Services provide the latest update on COVID-19 vaccine boosters, and influenza diagnosis, management and treatment.
Recording:
Presented by:
Whitney Essex, Dr. Jorge Mera
Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. He completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. During recent years Jorge’s efforts have been dedicated to organizing the Cherokee Nation HCV elimination program, as well as the HIV/HCV ECHO project. He is also the Director of the HIV clinic since 2012 and the Principal Investigator of the End the HIV Epidemic for the CNHS. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
Whitney Essex, MSN, FNP-BC, is a Family Nurse Practitioner for Cherokee Nation Health Services. Mrs. Essex works in the Infectious Diseases Department, where she is the coordinator for the Cherokee Nation Hepatitis C Elimination program. She assists in the maintenance of general infectious diseases clinical services, as well as the provision of medical care for patients accessing HIV, PrEP, Hepatitis C, and other infectious diseases-related services.
Resources Provided:
- Durability of immune responses to the BNT162b2 mRNA vaccine (biorxiv)
- Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021 (MMWR)
- COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect (JAMA)
- Considerations in boosting COVID-19 vaccine immune responses (Lancet)
- Who Is Eligible for a COVID-19 Vaccine Booster Shot? (CDC)
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season (CDC)
Date added: October 5, 2021